All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Immunic is developing a pipeline of oral therapies for chronic inflamm
…
Jun 21, 2023
proactiveinvestors.com
Immunic advances MS therapy vidofludimus calcium during Q3 - I
…
3 months ago
proactiveinvestors.co.uk
Immunic, Inc. Rings the Closing Bell
Dec 7, 2023
nasdaq.com
Immunic targets MS market with Phase 3 data - ICYMI
1 month ago
proactiveinvestors.com
Immunic's cutting-edge MS treatment approach: insights fro
…
Feb 15, 2024
proactiveinvestors.com
Immunic provides MS research update – ICYMI
11 months ago
proactiveinvestors.com
EQS-News: Immunic AG: Immunic, Inc. Reports Third Quarter 2025 Fi
…
3 months ago
finanznachrichten.de
Immunic reports successful 2023 and prepares for key 2025 milesto
…
Feb 22, 2024
proactiveinvestors.com
Immunic Therapeutics reaches major milestone with completion o
…
8 months ago
proactiveinvestors.com
Immunic CMO discusses significance of MS Awareness Mo
…
11 months ago
proactiveinvestors.co.uk
Immunic MS trial shows reduced brain lesions - ICYMI
1 week ago
yahoo.com
Immunic CEO on key 2025 highlights and 2026 milestones
1 month ago
proactiveinvestors.com
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed
…
Apr 30, 2024
proactiveinvestors.co.uk
Immunic reports first patient enrolled in investigator-sponsore
…
Sep 4, 2024
proactiveinvestors.com
Immunic CEO on Q3 highlights, ECTRIMS 2025 and upcoming mile
…
3 months ago
proactiveinvestors.com
Immunic showcases Phase 2 data on vidofludimus calcium at ACTRI
…
2 weeks ago
proactiveinvestors.com
10:31
Immunic showcases Phase 2 data on vidofludimus calcium at ACTRI
…
2 weeks ago
Yahoo
Proactive
Immunic CMO on CALLIPER MS trial results at ECTRIMS
4 months ago
proactiveinvestors.co.uk
Immunic Therapeutics shares IMU-856 mode of action and target for
…
Jun 26, 2023
proactiveinvestors.com
Immunic Therapeutics CMO Dr. Andreas Muehler on Positive Interi
…
Oct 23, 2024
proactiveinvestors.com
Immunic drug targeting post-COVID syndrome in Phase 2 trial - ICYMI
Sep 7, 2024
proactiveinvestors.com
0:20
ROTH Capital Partners and B2i Digital are pleased to announce th
…
57 views
4 weeks ago
Facebook
B2i Digital
Immunic's IMU-856 shows potential in gastrointestinal health trials - IC
…
Nov 16, 2024
proactiveinvestors.co.uk
Immunic says first patient enrolled in investigator-sponsored post-C
…
Sep 5, 2024
proactiveinvestors.com
9:54
Immunology Overview
1.4M views
Jan 31, 2012
YouTube
Armando Hasudungan
Immunic's IMU-856 shows promise as Celiac Disease Awareness Mon
…
9 months ago
proactiveinvestors.com.au
25:09
IMMUNE SYSTEM MADE EASY- IMMUNOLOGY INNATE AND ADA
…
2.5M views
Mar 1, 2020
YouTube
MEDSimplified
Immunic announces up to $240M financing extending cash runway
…
Jan 5, 2024
proactiveinvestors.com
IMMUNIC AKTIE | Kursziele | Analystenschätzungen | A2PHD4
5 months ago
finanzen.net
Immunic marks International Day of Persons with Disabilities with hop
…
2 months ago
proactiveinvestors.com
See more videos
More like this
Feedback
